BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 23891943)

  • 1. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
    Gutiérrez J; Vallejo B; Barbosa H; Pinzón J; Delgado G
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):321-8. PubMed ID: 23473403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morita-Baylis-Hillman adduct shows in vitro activity against Leishmania (Viannia) braziliensis associated with a reduction in IL-6 and IL-10 but independent of nitric oxide.
    Amorim FM; Rodrigues YK; Barbosa TP; Néris PL; Caldas JP; Sousa SC; Leite JA; Rodrigues-Mascarenhas S; Vasconcellos ML; Oliveira MR
    Parasitology; 2013 Jan; 140(1):29-38. PubMed ID: 22906971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
    Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
    Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
    Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
    J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions.
    Ayres DC; Pinto LA; Giorgio S
    J Parasitol; 2008 Dec; 94(6):1415-7. PubMed ID: 18576874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Effects of the Neolignan 2,3-Dihydrobenzofuran Against Leishmania Amazonensis.
    de Castro Oliveira LG; Brito LM; de Moraes Alves MM; Amorim LV; Sobrinho-Júnior EP; de Carvalho CE; da Franca Rodrigues KA; Arcanjo DD; das Graças Lopes Citó AM; de Amorim Carvalho FA
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):52-58. PubMed ID: 27398818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial activity and cytotoxicity of Brazilian plants.
    Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; Franca JR; Lage PS; Duarte MC; Andrade PH; Martins VT; Costa LE; Arruda AL; Faraco AA; Coelho EA; Castilho RO
    Exp Parasitol; 2014 Aug; 143():60-8. PubMed ID: 24846006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes.
    Pereira JC; Carregaro V; Costa DL; da Silva JS; Cunha FQ; Franco DW
    Eur J Med Chem; 2010 Sep; 45(9):4180-7. PubMed ID: 20598778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.